Alcohol Use Disorders
Global death rates from alcohol use disorders, country rankings, and trends from 1990 to 2023.
| # | Country | Rate | Region |
|---|
This page presents age-standardized death rates from alcohol use disorders across 204 countries and territories, drawing on data from the IHME Global Burden of Disease Study 2024. Alcohol Use Disorders mortality patterns vary considerably by geography, income level, and access to healthcare services. Understanding the epidemiology and population-level burden of alcohol use disorders is critical for global public health policy, disease prevention strategies, and healthcare resource allocation.
The trend chart above shows how the global alcohol use disorders rate has evolved since 1990, reflecting changes in risk factor prevalence, diagnostic capacity, treatment availability, and demographic transitions. Country rankings provide a comparative view of the current burden, highlighting disparities between high-income and low-income nations in alcohol use disorders outcomes.
Alcohol use disorders encompass a spectrum from harmful drinking to severe dependence, characterised by impaired control over consumption, tolerance, withdrawal symptoms, and continued use despite adverse consequences. Alcohol kills through multiple pathways: acute intoxication causes fatal poisoning, aspiration, and injury; chronic heavy use drives alcoholic liver disease (steatosis, hepatitis, cirrhosis), alcoholic cardiomyopathy, pancreatitis, and several cancers including oropharyngeal, oesophageal, hepatocellular, and colorectal malignancies. Globally, alcohol is attributable to approximately 3 million deaths per year — roughly 5.3% of all deaths — making it one of the leading preventable risk factors for premature mortality. The burden falls disproportionately on men, who account for over 75% of alcohol-attributable deaths. Eastern Europe and parts of sub-Saharan Africa experience the highest per-capita alcohol mortality, with Russia and surrounding nations historically exhibiting extreme rates of alcohol-related liver disease and poisoning. Economic costs extend far beyond health, encompassing lost productivity, criminal justice, and family disruption.
The WHO's SAFER initiative outlines five high-impact strategies: strengthening restrictions on alcohol availability, advancing and enforcing drink-driving countermeasures, facilitating access to screening and brief interventions, enforcing bans on alcohol advertising and promotion, and raising prices through taxation. Minimum unit pricing, implemented in Scotland and parts of Canada, has demonstrated reductions in alcohol-related hospitalisations and deaths. Treatment for alcohol use disorder includes pharmacotherapy (naltrexone, acamprosate, disulfiram) alongside psychosocial interventions such as cognitive behavioural therapy and mutual support groups.
Across the 209 countries tracked in this dataset, alcohol use disorders accounts for an average of 0.4% of total deaths. The highest share is recorded in Mongolia at 4.7%, while Saudi Arabia records the lowest at 0.01%. These figures reflect the most recent available data and illustrate the vast geographic variation in alcohol use disorders mortality burden.